URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Wojciech Zareba

Concepts (600)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Electrocardiography
119
1994
773
14.990
Why?
Long QT Syndrome
88
1994
387
14.080
Why?
Defibrillators, Implantable
86
2000
418
13.280
Why?
Myocardial Infarction
82
1994
660
11.280
Why?
Heart Rate
63
1995
461
9.820
Why?
Heart Failure
36
2004
367
7.940
Why?
Death, Sudden, Cardiac
67
1994
294
7.860
Why?
Heart Conduction System
28
1994
153
7.200
Why?
Electrocardiography, Ambulatory
37
1990
93
6.820
Why?
Tachycardia, Ventricular
37
1994
156
6.780
Why?
Ventricular Dysfunction, Left
30
2001
164
6.610
Why?
Arrhythmias, Cardiac
29
1994
246
5.040
Why?
Risk Assessment
64
2001
884
4.610
Why?
Cardiac Resynchronization Therapy
15
2010
89
4.020
Why?
Humans
301
1986
36274
3.810
Why?
Male
227
1986
19675
3.630
Why?
Risk Factors
98
1994
2345
3.580
Why?
Female
218
1986
19838
3.420
Why?
Arrhythmogenic Right Ventricular Dysplasia
11
2003
20
3.340
Why?
Middle Aged
139
1986
9837
3.030
Why?
Mutation
31
1995
1216
2.980
Why?
Ether-A-Go-Go Potassium Channels
13
2002
56
2.960
Why?
Genetic Predisposition to Disease
26
1999
331
2.920
Why?
Diagnosis, Computer-Assisted
8
2005
62
2.880
Why?
Electric Countershock
15
2004
95
2.790
Why?
Ventricular Fibrillation
15
2003
96
2.730
Why?
Coronary Disease
18
1990
258
2.700
Why?
Aged
105
1986
7269
2.670
Why?
Coronary Artery Disease
11
2003
96
2.630
Why?
Survival Analysis
41
1997
606
2.520
Why?
Myocardial Ischemia
15
1994
118
2.430
Why?
Proportional Hazards Models
56
1998
450
2.430
Why?
Stroke Volume
26
2002
154
2.430
Why?
KCNQ1 Potassium Channel
15
2002
76
2.400
Why?
Treatment Outcome
52
2001
2615
2.330
Why?
Adrenergic beta-Antagonists
27
1998
174
2.240
Why?
Prognosis
45
1994
1083
2.220
Why?
Adult
108
1986
11351
2.150
Why?
Atrial Fibrillation
10
2003
110
2.060
Why?
Cardiac Pacing, Artificial
8
2005
158
2.060
Why?
Anti-Arrhythmia Agents
10
1994
77
2.050
Why?
Follow-Up Studies
54
1994
1855
1.980
Why?
Genotype
37
1995
490
1.980
Why?
Cardiology
5
1991
54
1.950
Why?
Heart Arrest
23
1994
153
1.770
Why?
Heart Diseases
8
1991
142
1.760
Why?
Sodium Channels
10
1998
120
1.760
Why?
Sotalol
6
2003
16
1.700
Why?
Tachycardia, Sinus
3
1997
8
1.690
Why?
Polymorphism, Genetic
9
2001
201
1.680
Why?
Pacemaker, Artificial
7
2004
162
1.540
Why?
Time Factors
36
1990
3182
1.530
Why?
Torsades de Pointes
8
1997
32
1.510
Why?
Syncope
22
1994
115
1.510
Why?
Romano-Ward Syndrome
7
2007
37
1.510
Why?
Coronary Artery Bypass
4
2003
106
1.480
Why?
Signal Processing, Computer-Assisted
13
1995
101
1.460
Why?
Algorithms
10
2003
541
1.460
Why?
Recurrence
28
1997
691
1.420
Why?
Ventricular Premature Complexes
7
2003
18
1.400
Why?
Multivariate Analysis
23
1995
541
1.390
Why?
Randomized Controlled Trials as Topic
7
2003
411
1.380
Why?
Periodicals as Topic
2
2011
79
1.380
Why?
Ventricular Function, Left
7
2005
95
1.320
Why?
Potassium Channels, Voltage-Gated
6
2002
36
1.300
Why?
Phenotype
27
1995
763
1.300
Why?
Echocardiography
14
2000
228
1.290
Why?
Cardiomyopathy, Dilated
7
1994
42
1.280
Why?
Survival Rate
25
2000
618
1.240
Why?
Predictive Value of Tests
19
1994
606
1.230
Why?
Cardiovascular Diseases
10
2001
277
1.180
Why?
Severity of Illness Index
21
2001
922
1.150
Why?
Potassium Channels
8
2002
130
1.130
Why?
Sex Factors
16
1995
597
1.120
Why?
Adolescent
45
1986
4766
1.120
Why?
Kaplan-Meier Estimate
21
2007
222
1.100
Why?
Sensitivity and Specificity
20
1998
905
1.100
Why?
Prospective Studies
31
1999
1689
1.090
Why?
Ventricular Function
4
1995
36
1.080
Why?
Multicenter Studies as Topic
8
2001
129
1.070
Why?
Magnetic Resonance Imaging
4
2006
991
1.040
Why?
Retrospective Studies
23
1998
2267
1.040
Why?
Heart Ventricles
12
1990
207
1.040
Why?
Cardiac Resynchronization Therapy Devices
3
2011
13
1.010
Why?
Journal Impact Factor
2
2011
5
1.000
Why?
Bundle-Branch Block
6
2003
51
0.990
Why?
Aza Compounds
3
2008
23
0.980
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2002
48
0.970
Why?
Quinolines
3
2008
44
0.960
Why?
Environmental Exposure
4
2004
202
0.950
Why?
Anti-Infective Agents
3
2008
75
0.930
Why?
Biological Markers
16
2000
560
0.930
Why?
Air Pollutants
6
2001
179
0.920
Why?
Heterozygote
10
1998
125
0.910
Why?
Mutation, Missense
5
2002
87
0.910
Why?
Cause of Death
10
2001
162
0.890
Why?
Registries
21
1998
223
0.870
Why?
Telemedicine
3
2005
43
0.870
Why?
Practice Guidelines as Topic
7
2007
302
0.870
Why?
Angina, Unstable
6
1994
34
0.850
Why?
Child
32
1994
4155
0.830
Why?
Societies, Medical
5
2001
138
0.820
Why?
European Continental Ancestry Group
5
2006
234
0.810
Why?
Glomerular Filtration Rate
2
2006
88
0.800
Why?
Carbon
4
2004
81
0.800
Why?
Diabetes Mellitus, Type 2
4
2001
224
0.790
Why?
Muscle Proteins
2
2008
142
0.780
Why?
Cholesterol Ester Transfer Proteins
2
2007
15
0.770
Why?
Research Design
5
2002
336
0.770
Why?
Heart Failure, Diastolic
1
2011
1
0.760
Why?
Cohort Studies
14
1994
969
0.750
Why?
Lipoproteins
4
2001
98
0.740
Why?
United States
22
1991
2688
0.740
Why?
C-Reactive Protein
10
2002
122
0.720
Why?
Young Adult
17
2008
1059
0.720
Why?
Exercise
5
2001
182
0.720
Why?
Reproducibility of Results
15
1998
877
0.710
Why?
Sequence Deletion
2
2007
129
0.700
Why?
Chi-Square Distribution
16
1999
344
0.700
Why?
Posture
1
2010
110
0.690
Why?
von Willebrand Factor
4
1999
59
0.690
Why?
African Continental Ancestry Group
3
2006
125
0.680
Why?
Child, Preschool
22
1995
2660
0.680
Why?
Air Pollution
4
2005
44
0.670
Why?
Terminology as Topic
2
2006
109
0.660
Why?
DNA
2
2011
845
0.660
Why?
Hospitalization
7
2004
399
0.660
Why?
Lipids
10
1999
168
0.650
Why?
Consensus Development Conferences as Topic
1
2008
7
0.650
Why?
Ventricular Dysfunction
1
2008
7
0.650
Why?
Cation Transport Proteins
3
2002
22
0.650
Why?
Incidence
13
2006
685
0.640
Why?
Kidney Diseases
2
2009
170
0.640
Why?
Angioplasty, Balloon, Coronary
2
2005
66
0.630
Why?
Hypertension
3
2003
301
0.620
Why?
Obesity
3
2000
339
0.620
Why?
Smoking
3
2000
399
0.610
Why?
Infant
17
1995
2278
0.590
Why?
Physicians
2
2005
157
0.580
Why?
Hyperglycemia
1
2008
89
0.580
Why?
Age Factors
12
1995
1128
0.570
Why?
Cardiomyopathies
5
2003
82
0.570
Why?
Angiotensinogen
1
2006
8
0.560
Why?
Risk
9
2004
368
0.550
Why?
Polymorphism, Single Nucleotide
5
2007
90
0.550
Why?
Regression Analysis
11
1994
527
0.550
Why?
Particulate Matter
5
2006
48
0.550
Why?
Probability
10
2001
302
0.550
Why?
Models, Biological
2
2011
1008
0.550
Why?
Comorbidity
9
1999
380
0.540
Why?
Mental Health
1
2007
83
0.540
Why?
Attitude of Health Personnel
2
2005
289
0.530
Why?
Angioplasty, Balloon
1
2006
67
0.520
Why?
Heart
7
1995
236
0.520
Why?
Diabetes Mellitus
2
2001
169
0.520
Why?
Sex Distribution
9
2003
160
0.520
Why?
Models, Economic
1
2005
28
0.510
Why?
Circadian Rhythm
2
2004
84
0.510
Why?
Trans-Activators
3
2002
365
0.510
Why?
Cholesterol, HDL
5
2003
62
0.510
Why?
Aged, 80 and over
14
2004
2529
0.510
Why?
Gonadal Steroid Hormones
1
2005
35
0.500
Why?
Public Opinion
1
2005
17
0.500
Why?
Critical Illness
1
2005
52
0.480
Why?
Health Care Costs
1
2005
113
0.480
Why?
Choice Behavior
1
2005
46
0.470
Why?
Tachycardia, Supraventricular
3
1990
19
0.470
Why?
Sequence Analysis, Protein
1
2003
14
0.460
Why?
Ion Channels
9
1995
153
0.460
Why?
Steroids
1
2004
54
0.450
Why?
Reference Values
6
1999
439
0.450
Why?
Statistics, Nonparametric
11
2001
262
0.450
Why?
Case-Control Studies
9
1997
617
0.450
Why?
DNA-Binding Proteins
3
2002
685
0.450
Why?
Pirenzepine
1
2003
4
0.440
Why?
Jervell-Lange Nielsen Syndrome
3
2002
11
0.440
Why?
Sequence Alignment
1
2003
191
0.430
Why?
Haloperidol
1
2003
38
0.430
Why?
Myocardial Contraction
3
2011
111
0.430
Why?
Myocardium
3
2006
294
0.430
Why?
Autonomic Nervous System
5
2001
68
0.420
Why?
Ventricular Remodeling
3
2010
38
0.420
Why?
Particle Size
9
2002
199
0.420
Why?
Drug Approval
1
2002
20
0.400
Why?
Logistic Models
11
2000
611
0.400
Why?
Age Distribution
8
2003
221
0.390
Why?
Electrophysiology
9
1994
247
0.380
Why?
Antipsychotic Agents
1
2003
114
0.380
Why?
Inflammation
6
2002
534
0.380
Why?
Patient Selection
4
2008
212
0.370
Why?
Disease Progression
7
2002
521
0.370
Why?
Blood Urea Nitrogen
4
2005
43
0.360
Why?
Analysis of Variance
6
1994
736
0.350
Why?
Monitoring, Physiologic
2
2010
100
0.340
Why?
Spain
4
2008
19
0.340
Why?
Mortality
3
1997
89
0.340
Why?
Metabolic Syndrome X
3
2003
60
0.340
Why?
Odds Ratio
8
1995
315
0.340
Why?
Cholesterol
3
1997
137
0.340
Why?
Ion Channel Gating
2
2011
127
0.330
Why?
Myocardial Revascularization
2
2006
22
0.330
Why?
Biopsy
2
2010
362
0.320
Why?
Recovery of Function
2
2009
107
0.320
Why?
Equipment Design
5
2006
248
0.320
Why?
Hospital Mortality
3
2006
137
0.310
Why?
Baroreflex
3
2004
22
0.310
Why?
Blood Pressure
4
2007
467
0.310
Why?
Connexin 43
2
2006
40
0.310
Why?
Up-Regulation
3
2006
363
0.310
Why?
Diphenhydramine
1
1997
9
0.310
Why?
Histamine H1 Antagonists
1
1997
16
0.300
Why?
DNA Mutational Analysis
5
2002
189
0.300
Why?
Clinical Trials as Topic
6
2002
671
0.300
Why?
Evidence-Based Medicine
2
2009
202
0.290
Why?
ROC Curve
5
1998
126
0.290
Why?
Death
2
2003
23
0.290
Why?
Equipment Failure
4
2008
72
0.280
Why?
KCNQ Potassium Channels
4
2002
18
0.280
Why?
Asthma
3
1999
317
0.280
Why?
Fibrin Fibrinogen Degradation Products
4
1999
50
0.280
Why?
Women's Health
1
1997
60
0.280
Why?
New York
6
2001
1305
0.280
Why?
Phospholipases A
2
2006
37
0.270
Why?
Body Mass Index
3
2000
218
0.270
Why?
Angina Pectoris
4
1994
49
0.270
Why?
Plasminogen Activator Inhibitor 1
3
1999
40
0.270
Why?
Inhalation Exposure
2
2007
88
0.270
Why?
Hemodynamics
2
2002
272
0.260
Why?
Pregnancy Complications, Cardiovascular
3
1998
38
0.260
Why?
Genetic Testing
5
2003
96
0.260
Why?
Databases, Factual
2
2005
156
0.250
Why?
Infant, Newborn
8
2007
1844
0.240
Why?
Prevalence
3
2003
562
0.240
Why?
Therapy, Computer-Assisted
2
2008
12
0.240
Why?
Coronary Vessels
2
2004
132
0.240
Why?
Canada
3
2007
75
0.230
Why?
Blood Glucose
3
2001
464
0.230
Why?
Flecainide
2
2001
12
0.230
Why?
Testosterone
2
2004
158
0.230
Why?
Confidence Intervals
3
2007
165
0.220
Why?
Convalescence
3
1994
19
0.220
Why?
Dose-Response Relationship, Drug
3
1997
1117
0.220
Why?
Pedigree
3
2002
231
0.220
Why?
Enzyme-Linked Immunosorbent Assay
3
1999
462
0.220
Why?
Patient Admission
2
2007
85
0.220
Why?
Ventricular Dysfunction, Right
2
2009
18
0.220
Why?
Thrombosis
4
1999
200
0.220
Why?
International Cooperation
2
1998
69
0.210
Why?
Age of Onset
3
2001
126
0.210
Why?
Japan
2
2007
30
0.210
Why?
Combined Modality Therapy
4
1986
486
0.210
Why?
Remote Sensing Technology
1
2012
2
0.200
Why?
Serum Amyloid A Protein
4
2002
23
0.200
Why?
Cross-Over Studies
2
2009
128
0.200
Why?
Ventricular Function, Right
3
2005
26
0.200
Why?
Thrombospondins
1
2011
13
0.200
Why?
Emotions
2
2001
91
0.200
Why?
Defibrillators
1
2011
6
0.200
Why?
Arteritis
1
2011
15
0.200
Why?
Israel
2
2007
38
0.200
Why?
Ventricular Outflow Obstruction
1
2011
11
0.200
Why?
Oxidants, Photochemical
1
2011
28
0.200
Why?
Survivors
2
2006
118
0.200
Why?
Coronary Care Units
1
2011
18
0.190
Why?
Genetic Variation
2
2008
151
0.190
Why?
Hemostasis
2
1999
62
0.190
Why?
Referral and Consultation
2
2010
196
0.190
Why?
Drug Therapy, Combination
2
2008
382
0.190
Why?
Cardiotoxins
1
2011
3
0.190
Why?
Guideline Adherence
2
2008
83
0.190
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.190
Why?
Menopause
1
2011
43
0.190
Why?
Tachycardia, Paroxysmal
1
2010
11
0.190
Why?
Enalapril
1
2010
6
0.190
Why?
Cooperative Behavior
1
2012
101
0.190
Why?
Heart Defects, Congenital
1
2011
103
0.190
Why?
Spironolactone
1
2010
12
0.190
Why?
Ozone
1
2011
83
0.190
Why?
Language
1
2011
28
0.190
Why?
Databases, Genetic
1
2010
26
0.190
Why?
Heart Function Tests
3
2001
33
0.180
Why?
Diagnosis, Differential
3
2000
874
0.180
Why?
Pattern Recognition, Automated
2
2005
26
0.180
Why?
Drug Evaluation, Preclinical
1
2011
76
0.180
Why?
Gene Frequency
2
2006
88
0.180
Why?
Electrodes, Implanted
1
2011
57
0.180
Why?
Cardiology Service, Hospital
1
2010
3
0.180
Why?
Societies, Nursing
1
2010
3
0.180
Why?
Primary Prevention
2
2007
58
0.180
Why?
Heavy Ions
1
2010
2
0.180
Why?
Guidelines as Topic
1
2011
89
0.180
Why?
Adrenergic beta-Agonists
2
1999
51
0.180
Why?
Reference Standards
1
2010
45
0.180
Why?
Forecasting
3
1998
177
0.180
Why?
Hypertriglyceridemia
2
2006
24
0.180
Why?
Hospital Units
1
2010
20
0.180
Why?
Blood Coagulation Factors
4
2000
50
0.180
Why?
Disease-Free Survival
3
2001
198
0.170
Why?
Life Change Events
1
2010
106
0.170
Why?
Internet
2
2007
98
0.170
Why?
Magnetic Resonance Angiography
1
2010
37
0.170
Why?
Physician's Practice Patterns
2
2008
243
0.170
Why?
Acute Coronary Syndrome
1
2009
10
0.170
Why?
Radiation Dosage
1
2010
125
0.170
Why?
Critical Care
1
2010
64
0.170
Why?
Germany
4
2005
26
0.170
Why?
Happiness
1
2009
12
0.170
Why?
Silicones
1
2009
27
0.160
Why?
Statistics as Topic
3
2001
185
0.160
Why?
Tachycardia
2
1986
67
0.160
Why?
Hemostasis, Surgical
1
2008
12
0.160
Why?
Lipase
1
2008
16
0.160
Why?
Lipoprotein(a)
1
2008
15
0.160
Why?
Apolipoprotein A-I
1
2008
23
0.160
Why?
Punctures
1
2008
24
0.160
Why?
Coronary Angiography
3
1998
85
0.160
Why?
Coagulants
1
2008
13
0.160
Why?
Double-Blind Method
2
2005
992
0.160
Why?
Conserved Sequence
1
2009
103
0.160
Why?
Acetanilides
1
2008
9
0.160
Why?
Vagus Nerve
1
2008
40
0.160
Why?
Hypercholesterolemia
2
2005
50
0.160
Why?
Asian Continental Ancestry Group
1
2008
30
0.160
Why?
Chromatography, High Pressure Liquid
3
2002
208
0.160
Why?
Diagnostic Errors
1
2009
90
0.160
Why?
Femoral Artery
1
2008
80
0.160
Why?
Siblings
1
2008
36
0.150
Why?
Delayed Rectifier Potassium Channels
1
2008
10
0.150
Why?
Atrial Flutter
1
2008
25
0.150
Why?
Triglycerides
2
2003
104
0.150
Why?
Coronary Stenosis
2
2004
7
0.150
Why?
Fractals
3
2001
7
0.150
Why?
Cost-Benefit Analysis
2
2005
215
0.150
Why?
Catheter Ablation
1
2009
73
0.150
Why?
Discriminant Analysis
1
2007
22
0.150
Why?
Medical History Taking
1
2008
62
0.150
Why?
Piperazines
1
2008
74
0.150
Why?
Postoperative Complications
2
2001
733
0.150
Why?
Quality of Life
2
2007
502
0.150
Why?
African Americans
1
2010
219
0.150
Why?
Sodium
1
2008
298
0.150
Why?
Aryldialkylphosphatase
1
2007
6
0.150
Why?
Europe
3
2011
80
0.150
Why?
Natriuretic Peptide, Brain
1
2007
11
0.150
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2007
5
0.150
Why?
Pregnancy, High-Risk
1
2007
14
0.140
Why?
Cardiac Output, Low
1
2007
16
0.140
Why?
Patient Education as Topic
2
2005
214
0.140
Why?
International Normalized Ratio
1
2006
8
0.140
Why?
E-Selectin
1
2006
17
0.140
Why?
Vehicle Emissions
1
2007
23
0.140
Why?
Hypolipidemic Agents
2
2002
26
0.140
Why?
Kidney
1
2010
586
0.140
Why?
Hemorrhage
1
2008
180
0.140
Why?
Aging
2
1998
707
0.140
Why?
NADPH Oxidase
1
2007
30
0.140
Why?
Radiotherapy, High-Energy
1
2006
24
0.140
Why?
Diabetic Angiopathies
1
2007
34
0.140
Why?
Point Mutation
2
2003
172
0.140
Why?
User-Computer Interface
1
2007
42
0.140
Why?
Threonine
1
2006
29
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
66
0.140
Why?
Methionine
1
2006
52
0.140
Why?
Education, Medical, Continuing
1
2007
64
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
267
0.140
Why?
Protein Precursors
1
2007
84
0.140
Why?
Homozygote
1
2006
97
0.140
Why?
Rest
1
2006
22
0.140
Why?
Surgical Procedures, Elective
1
2006
32
0.140
Why?
Health Personnel
1
2006
59
0.130
Why?
Outcome Assessment (Health Care)
2
2005
301
0.130
Why?
Electrophysiologic Techniques, Cardiac
1
2005
24
0.130
Why?
Arousal
2
2000
56
0.130
Why?
Paper
1
2005
8
0.130
Why?
Pregnancy Outcome
1
2007
137
0.130
Why?
Apolipoproteins B
2
2000
153
0.130
Why?
Information Storage and Retrieval
1
2005
29
0.130
Why?
Stress, Psychological
1
2009
285
0.130
Why?
Poland
1
2005
12
0.130
Why?
Dehydroepiandrosterone Sulfate
1
2005
7
0.130
Why?
Intercellular Adhesion Molecule-1
1
2006
125
0.130
Why?
Epidemiologic Studies
1
2005
22
0.130
Why?
Medical Records Systems, Computerized
1
2005
34
0.130
Why?
Zinc Oxide
1
2005
7
0.130
Why?
Follicle Stimulating Hormone
1
2005
52
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
48
0.130
Why?
Diabetes Complications
1
2005
66
0.130
Why?
Insulin
3
1999
668
0.130
Why?
Molecular Sequence Data
3
2002
1988
0.130
Why?
Heart Rupture, Post-Infarction
1
2004
1
0.120
Why?
Peptide Fragments
1
2007
282
0.120
Why?
Contrast Media
1
2007
267
0.120
Why?
Prostheses and Implants
1
2005
87
0.120
Why?
Amino Acid Sequence
2
2003
1195
0.120
Why?
Software
1
2005
125
0.120
Why?
Postoperative Period
1
2004
84
0.120
Why?
Sympathectomy
1
2004
21
0.120
Why?
Intermittent Claudication
1
2004
10
0.120
Why?
Heterozygote Detection
2
1999
25
0.120
Why?
Genes, Recessive
1
2003
38
0.110
Why?
Primary Health Care
1
2008
487
0.110
Why?
Endpoint Determination
1
2003
31
0.110
Why?
Thioridazine
1
2003
1
0.110
Why?
Risk Sharing, Financial
1
2003
4
0.110
Why?
Estradiol
1
2004
194
0.110
Why?
Hyperlipidemias
1
2003
45
0.110
Why?
Drug Labeling
1
2003
12
0.110
Why?
Benzodiazepines
1
2003
26
0.110
Why?
Dopamine Antagonists
1
2003
22
0.110
Why?
Apolipoproteins
4
2000
41
0.110
Why?
Atropine
1
2002
33
0.110
Why?
Lipoproteins, HDL
2
1997
33
0.110
Why?
Androgens
1
2004
141
0.110
Why?
History, 20th Century
2
1991
244
0.100
Why?
Exercise Test
3
1994
101
0.100
Why?
United States Food and Drug Administration
1
2002
45
0.100
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2001
3
0.100
Why?
Hyperhomocysteinemia
1
2001
3
0.100
Why?
Leukocyte Count
1
2001
161
0.100
Why?
Blood Proteins
1
2001
95
0.100
Why?
Endothelium, Vascular
2
2001
406
0.100
Why?
Gene Expression Profiling
1
2003
301
0.090
Why?
Sex Characteristics
2
1998
138
0.090
Why?
World Health
2
2011
63
0.090
Why?
Cardiolipins
1
2000
7
0.090
Why?
Models, Molecular
3
2002
355
0.090
Why?
Diabetes Mellitus, Type 1
1
2001
166
0.090
Why?
Longitudinal Studies
2
1997
395
0.090
Why?
Autoantibodies
1
2000
98
0.090
Why?
Electroencephalography
1
2000
176
0.090
Why?
Latex Fixation Tests
1
1999
18
0.090
Why?
Swimming
1
1999
9
0.090
Why?
Questionnaires
1
2005
1004
0.090
Why?
Amino Acid Substitution
2
2007
124
0.080
Why?
Polymorphism, Single-Stranded Conformational
3
2002
40
0.080
Why?
Acoustic Stimulation
1
1999
173
0.080
Why?
Creatinine
2
2007
127
0.080
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2006
15
0.080
Why?
Physicians, Family
2
2008
109
0.080
Why?
Codon, Nonsense
2
2007
56
0.080
Why?
Models, Animal
2
2006
138
0.070
Why?
Lipoproteins, LDL
1
1997
31
0.070
Why?
Systole
2
2005
39
0.070
Why?
Membrane Potentials
2
2007
340
0.070
Why?
Phospholipases A2
2
2006
28
0.070
Why?
Sleep
2
2001
59
0.070
Why?
Family Health
3
1998
90
0.070
Why?
Rabbits
2
2006
697
0.070
Why?
Action Potentials
2
1990
250
0.070
Why?
Amiodarone
2
2002
10
0.070
Why?
Cerebrovascular Disorders
1
1997
115
0.070
Why?
Chromosomes, Human, Pair 7
1
1995
21
0.070
Why?
Chromosomes, Human, Pair 3
1
1995
19
0.070
Why?
Chromosomes, Human, Pair 11
1
1995
30
0.070
Why?
Life Tables
2
2004
39
0.070
Why?
Family
2
2001
201
0.070
Why?
Administration, Inhalation
2
2005
175
0.060
Why?
Pregnancy
3
1998
1966
0.060
Why?
Genetic Markers
2
2003
134
0.060
Why?
Suicide, Attempted
1
1997
210
0.060
Why?
Sputum
2
2004
57
0.060
Why?
Nitric Oxide
2
2004
250
0.060
Why?
Metoprolol
2
2000
10
0.060
Why?
Atenolol
2
2000
13
0.060
Why?
Blood Coagulation
2
2000
67
0.050
Why?
Sequence Analysis, DNA
2
2002
166
0.050
Why?
Nonlinear Dynamics
2
2001
35
0.050
Why?
Precipitating Factors
1
2011
6
0.050
Why?
Genome-Wide Association Study
1
2011
21
0.050
Why?
Genetic Association Studies
1
2011
19
0.050
Why?
Animals
4
2006
16093
0.050
Why?
Glucose Intolerance
1
2011
25
0.050
Why?
Glucose Tolerance Test
1
2011
68
0.050
Why?
Estrogen Replacement Therapy
1
2011
21
0.050
Why?
Environmental Monitoring
1
2011
62
0.050
Why?
Echocardiography, Doppler
1
2011
53
0.050
Why?
RNA, Messenger
2
2006
1863
0.050
Why?
Computers, Handheld
1
2010
10
0.050
Why?
Minnesota
1
2010
27
0.050
Why?
Atmosphere
1
2010
1
0.050
Why?
National Institutes of Health (U.S.)
2
2001
63
0.050
Why?
Climate
1
2010
4
0.050
Why?
Polymerase Chain Reaction
2
2003
596
0.050
Why?
Blood Volume
1
2010
53
0.050
Why?
Endocardium
1
2010
9
0.050
Why?
Desmosomes
1
2010
4
0.040
Why?
Oocytes
1
2011
135
0.040
Why?
Temperature
1
2010
242
0.040
Why?
Xenopus laevis
1
2011
167
0.040
Why?
Models, Statistical
1
2011
226
0.040
Why?
Protein Structure, Secondary
1
2009
86
0.040
Why?
Obesity, Morbid
1
2010
50
0.040
Why?
Dose-Response Relationship, Radiation
1
2010
219
0.040
Why?
Causality
1
2009
45
0.040
Why?
Early Ambulation
1
2008
5
0.040
Why?
Angiography
1
2009
93
0.040
Why?
Computer Simulation
1
2011
302
0.040
Why?
Fibrinogen
2
1999
149
0.040
Why?
Health Care Surveys
1
2010
161
0.040
Why?
Continental Population Groups
1
2010
121
0.040
Why?
Administration, Topical
1
2008
89
0.040
Why?
Decision Support Systems, Clinical
1
2008
22
0.040
Why?
Pressure
1
2008
130
0.040
Why?
Computational Biology
1
2009
67
0.040
Why?
Interviews as Topic
1
2009
177
0.040
Why?
Minority Groups
1
2008
56
0.040
Why?
Oscillometry
1
2008
25
0.040
Why?
Chromosome Mapping
2
1995
227
0.040
Why?
Genetic Linkage
2
1995
158
0.040
Why?
Frameshift Mutation
1
2007
22
0.040
Why?
Patient Satisfaction
1
2009
226
0.040
Why?
RNA Splice Sites
1
2007
17
0.040
Why?
Netherlands
1
2007
29
0.040
Why?
Mutagenesis, Insertional
1
2007
53
0.040
Why?
Ion Transport
1
2007
70
0.040
Why?
Postpartum Period
1
2007
38
0.040
Why?
Rats, Inbred SHR
1
2007
43
0.040
Why?
Sulfur Dioxide
1
2006
11
0.040
Why?
Injections, Intraperitoneal
1
2007
84
0.040
Why?
Glutamine
1
2007
63
0.040
Why?
Aspartic Acid
1
2007
46
0.040
Why?
Parity
1
2007
49
0.040
Why?
Telemetry
1
2007
26
0.040
Why?
Patient Readmission
1
2007
39
0.040
Why?
Aerosols
1
2007
115
0.040
Why?
Carbon Monoxide
1
2006
53
0.040
Why?
Internationality
1
2006
26
0.040
Why?
Arginine
1
2007
108
0.030
Why?
Automobile Driving
1
2007
33
0.030
Why?
Nitrous Oxide
1
2006
40
0.030
Why?
Glutamic Acid
1
2007
97
0.030
Why?
Protein Transport
1
2007
168
0.030
Why?
Enzyme Inhibitors
1
2008
422
0.030
Why?
Models, Cardiovascular
1
2006
70
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Gap Junctions
1
2006
66
0.030
Why?
Potassium
1
2007
304
0.030
Why?
Database Management Systems
1
2005
13
0.030
Why?
Propanolamines
1
2005
11
0.030
Why?
Gestational Age
1
2007
339
0.030
Why?
Placebo Effect
1
2005
35
0.030
Why?
Carbazoles
1
2005
28
0.030
Why?
Artificial Intelligence
1
2005
23
0.030
Why?
Protein Structure, Tertiary
1
2007
347
0.030
Why?
Lipopolysaccharides
1
2007
211
0.030
Why?
Length of Stay
1
2007
287
0.030
Why?
Equipment Failure Analysis
1
2005
71
0.030
Why?
Massachusetts
1
2005
32
0.030
Why?
Advisory Committees
1
2005
21
0.030
Why?
Smoking Cessation
1
2006
80
0.030
Why?
Radiotherapy
1
2006
198
0.030
Why?
Lymphocyte Subsets
1
2004
27
0.030
Why?
Respiratory System
1
2005
46
0.030
Why?
Heart Atria
1
2005
68
0.030
Why?
Cardiovascular System
1
2004
46
0.030
Why?
Ganglionectomy
1
2004
7
0.030
Why?
Blotting, Western
1
2006
645
0.030
Why?
Respiration
1
2004
181
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
542
0.030
Why?
Blood Chemical Analysis
1
2003
39
0.030
Why?
Factor Analysis, Statistical
1
2003
57
0.030
Why?
Diseases in Twins
1
2003
38
0.030
Why?
Rare Diseases
1
2003
27
0.030
Why?
Oxidative Stress
1
2007
346
0.030
Why?
Clinical Protocols
1
2003
106
0.030
Why?
Nucleic Acid Denaturation
1
2003
48
0.030
Why?
Immunohistochemistry
1
2006
1064
0.030
Why?
Entropy
1
2002
9
0.030
Why?
Exons
1
2003
168
0.030
Why?
Introns
1
2003
111
0.030
Why?
Hearing Loss, Sensorineural
1
2002
20
0.030
Why?
Principal Component Analysis
1
2001
31
0.020
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2001
5
0.020
Why?
Mexiletine
1
2001
11
0.020
Why?
Drug Monitoring
1
2001
41
0.020
Why?
beta 2-Glycoprotein I
1
2000
4
0.020
Why?
Cytokines
1
2004
565
0.020
Why?
Mitral Valve Insufficiency
1
2000
24
0.020
Why?
Immunoglobulin M
1
2000
141
0.020
Why?
Nadolol
1
2000
5
0.020
Why?
Administration, Oral
1
2001
308
0.020
Why?
Propranolol
1
2000
82
0.020
Why?
Bias (Epidemiology)
1
2000
44
0.020
Why?
Automation
1
1999
31
0.020
Why?
Binding Sites
1
2002
690
0.020
Why?
Factor VII
1
1999
8
0.020
Why?
Factor VIIa
1
1999
16
0.020
Why?
Pilot Projects
1
2001
442
0.020
Why?
Evaluation Studies as Topic
1
1999
245
0.020
Why?
Chronic Disease
1
2001
522
0.020
Why?
Glycoproteins
1
2000
201
0.020
Why?
Rats
1
2007
4289
0.020
Why?
Stress, Physiological
1
2000
107
0.020
Why?
Immunoglobulin G
1
2000
488
0.020
Why?
Acute Disease
1
2000
586
0.020
Why?
Abortion, Induced
1
1998
46
0.020
Why?
Base Sequence
1
2002
1683
0.020
Why?
Thallium Radioisotopes
1
1997
14
0.020
Why?
Gene Expression
1
2000
751
0.020
Why?
Arrhythmia, Sinus
1
1995
7
0.020
Why?

Visualizations


Zareba's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department